PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, will be showcasing a family of new Microcyn-based healthcare products including a Medicare-reimbursable wound and skin care hydrogel at the Symposium on Advanced Wound Care (booth #934) being held in Orlando, Florida on April 17-20, 2010.
